This session provides in-depth knowledge on imaging planning for mitral valve-in-valve procedures, focusing on echocardiography and CT scan assessment. Learn the critical role of intraprocedural imaging guidance to ensure procedural success and patient safety during mitral valve-in-valve interventions.

Discover a selection of cases showcasing the key features of the Navitor Valve System and its clinical applications. This session explores auxiliary access, the use of Navitor in alternative access and complex PCI, its performance in challenging peripheral anatomies, and innovative outcomes with the Vantage 30D...

This session presents challenging clinical cases focusing on post-TAVI paravalvular leakage and the percutaneous closure of paravalvular leaks following surgically implanted Intuity valves. Gain valuable insights into complex management strategies and procedural techniques addressing these complications.

Join this comprehensive session to explore the Myval transcatheter heart valve series, featuring the latest clinical updates from two large randomized controlled trials—Landmark and Compare TAVI. Learn from real-world experiences, including recorded cases, and understand how these innovations translate to complex patient demographics in daily TAVI...

A 65-year-old female with a history of atrial fibrillation, LAD PCI (2016), ICD implantation (2016), stroke, and insulin-dependent DM, presented with symptomatic severe secondary mitral regurgitation and poor left ventricular function (LVEF 20%). A single MitraClip was implanted under general anesthesia and TEE guidance.

LIVE Educational Case...

This workshop provides a comprehensive understanding of tricuspid valve anatomy, echocardiographic screening, and procedural guidance essential for successful tricuspid TEER. Learn to distinguish suitable candidates and gain hands-on experience with intra-procedural echocardiography techniques.

Complications

Perforations can be life threating complications, but if recognised quickly and managed correctly can have a positive outcome. This section explains how to treat a coronary perforation.
In total there are 5 types.

PCR Complication Team: Patrick Calvert, Eric Eeckhout, Michael Haude, Amir Lerman, Olivier Muller

There are five types...

How would you treat this 62-year-old female patient with NYHA class III/IV symptoms, degeneration of mitral valve repair (with annuloplasty ring - 2008) with significant MR, and high surgical risk?

View the case of a 60-year-old male patient who was diagnosed with pulmonary embolism and a large TIT, and see how he was treated by percutaneous thrombectomy.

The authors present a case of percutaneous coronary intervention for bifurcation lesion in a 73-year-old man suffering from effort angina, in which they successfully performed double kissing crush stenting using optical coherence tomography.

Watch the case of a 79-year-old male patient admitted to hospital with progressive dyspnea in NYHA functional class III-IV and signs of fluid overload, who presented a subannular perforation of LVOT in the region of fibrous aortomitral continuity, and find out how he was treated.

Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.

Because of the current COVID-19 environment with an exponential development of ‘digital format of postgraduate learning events’, often on the same topics, it seems essential to remember the foundation of effective post graduate learning in the field of medicine, and how we...

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...